Amanote Research

Amanote Research

    RegisterSign In

The Impact of State Parity Laws on Copayments for and Adherence to Oral Endocrine Therapy for Breast Cancer

Cancer - United States
doi 10.1002/cncr.31910
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

December 19, 2018

Authors
Alexander L. ChinJason P. BentleyErqi L. Pollom
Publisher

Wiley


Related search

More Evidence on the Limited Impact of State Oral Oncology Parity Laws

Cancer
Cancer ResearchOncology
2018English

Predicting Response/Resistance to Endocrine Therapy for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

The Impact of Breast Care Nurses on Patients’ Satisfaction, Understanding of the Disease, and Adherence to Adjuvant Endocrine Therapy

Breast Care
SurgeryOncology
2011English

Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Interventions to Promote Adherence to Endocrine Therapy Among Breast Cancer Survivors: A Meta-Analysis

Psycho-Oncology
PsychiatryMental HealthOncologyExperimentalCognitive Psychology
2018English

Endocrine Therapy of Breast Cancer

2008English

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

How to Improve Endocrine Therapy of Breast Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

Drugs for Cancer and Copayments

BMJ
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy